Bilateral adrenal hyperplasia and NR3C1 mutations causing glucocorticoid resistance: Is there an association?

Eur J Endocrinol. 2018 Oct 12;179(5):C1-C4. doi: 10.1530/EJE-18-0471.


Glucocorticoids signal through their cognate, ubiquitously expressed glucocorticoid receptor (GR), which influences the transcription of a large number of target genes. Several genetic defects, including point mutations, deletions or insertions in the NR3C1 gene that encodes the GR, have been associated with familial or sporadic generalized glucocorticoid resistance or Chrousos syndrome. One of the clinical manifestations of this rare endocrine condition is bilateral adrenal hyperplasia due to compensatory elevations of plasma ACTH concentrations. In this commentary, we discuss the interesting findings of the recently published French MUTA-GR Study, and present our perspective on the evolving field of NR3C1 pathology.

Publication types

  • Comment

MeSH terms

  • Glucocorticoids*
  • Humans
  • Hyperplasia
  • Mutation
  • Prevalence
  • Receptors, Glucocorticoid / genetics*


  • Glucocorticoids
  • NR3C1 protein, human
  • Receptors, Glucocorticoid